XML 66 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):
September 30, 2023December 31, 2022
Cash and cash equivalents$259,935 $337,087 
Restricted cash6,138 6,139 
Total cash, cash equivalents and restricted cash$266,073 $343,226 
Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands):
September 30, 2023December 31, 2022
Cash and cash equivalents$259,935 $337,087 
Restricted cash6,138 6,139 
Total cash, cash equivalents and restricted cash$266,073 $343,226 
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of basic and diluted net loss per share (in thousands, except shares and per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Basic loss per share:
Net loss from continuing operations$(84,485)$(105,802)$(222,062)$(329,129)
Less: net loss attributable to non-controlling interest98 26 341 
Net loss from continuing operations available to common shareholders
(84,480)(105,704)(222,036)(328,788)
Net income (loss) from discontinued operations, net of tax
669 (46,944)4,672 (80,708)
Net loss attributable to common shareholders$(83,811)$(152,648)$(217,364)$(409,496)
Shares used in computation:
Weighted-average common shares outstanding292,693,961 186,750,504 270,078,947 176,503,992 
Basic and diluted loss per share from continuing operations $(0.29)$(0.57)$(0.82)$(1.86)
Basic and diluted loss per share from discontinued operations $— $(0.25)$0.02 $(0.46)
Basic and diluted loss per share$(0.29)$(0.82)$(0.80)$(2.32)
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share
The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:
September 30,
20232022
Warrants to purchase common stock166,670 166,670 
Stock options19,103,190 15,655,673 
Unvested restricted stock units14,090,914 6,859,083 
Convertible notes variable settlement feature6,966,078 6,966,078 
Total40,326,852 29,647,504